SacI-81

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameSacI-81
Drug Alias NameSacI-81SacI81
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsTriple-positive breast cancer (HR+/HER2+)Endometrial NeoplasmsCarcinoma, Non-Small-Cell Lung +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorellia AI
China Registration ClassN/A

Develop Information

Active CompaniesCorellia AI
Inactive CompaniesN/A
Active IndicationsTriple-positive breast cancer (HR+/HER2+)Endometrial NeoplasmsCarcinoma, Non-Small-Cell Lung +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A